img +44 (0) 203 219 3599
  • Follow us:
Asprin may not protect against all bowel cancer


26th Jun


A number of studies have suggested the protective effect of aspirin in preventing the development of bowel cancer. A recent study in the Journal of American Medical Association (JAMA) by Nishihara and colleagues at the Dana Faber Institute in Boston, USA,  has suggested that this protective effect may be confined to particular ‘molecular’ subtypes of bowel cancer. Through research we are increasingly aware that bowel cancer is not just a single disease, but a number of diseases with different genetic and molecular causes. This is likely to have a profound effect in our future strategies to prevent and treat gastrointestinal cancer. For now regular aspirin is not routinely recommended for the prevention of bowel cancer, but this and other studies are likely to inform cancer prevention in the near future.

Share This Article: